Aurora Cannabis Inc. (T:ACB)
Business Focus: Alternative Medicine
Apr 01, 2024 07:00 am ET
Aurora Cannabis Commends Germany's Landmark Legalization Achievement
NASDAQ | TSX: ACB
Apr 01, 2024 07:00 am ET
Aurora Cannabis Commends Germany's Landmark Legalization Achievement
NASDAQ | TSX: ACB
Mar 20, 2024 07:15 am ET
Aurora Cannabis Achieves Australia's TGA GMP Certification, Setting Global Standard for Quality and Compliance
Milestone Achievement Signals Company's Commitment to Solidifying its Leadership in the Australian Market
Mar 18, 2024 12:09 pm ET
Canadian Investment Regulatory Organization Trading Halt - ACB.WT.U
TORONTO, March 18, 2024 /CNW/ - The following issues have been halted by CIRO:
Mar 04, 2024 08:30 am ET
Feb 29, 2024 04:00 pm ET
Feb 28, 2024 06:00 am ET
Feb 20, 2024 06:00 am ET
Feb 20, 2024 06:00 am ET
Feb 08, 2024 06:00 am ET
Feb 08, 2024 06:00 am ET
Feb 08, 2024 05:45 am ET
Aurora Cannabis Acquires MedReleaf Australia
NASDAQ | TSX: ACB
Feb 08, 2024 05:45 am ET
Aurora Cannabis Acquires MedReleaf Australia
NASDAQ | TSX: ACB
Jan 31, 2024 06:00 am ET
Jan 31, 2024 06:00 am ET
Jan 26, 2024 11:21 am ET
Canadian Investment Regulatory Organization Trading Halt - ACB.WT.V
TORONTO, Jan. 26, 2024 /CNW/ - The following issues have been halted by CIRO:
Jan 24, 2024 06:55 am ET
Jan 24, 2024 06:55 am ET
Nov 09, 2023 03:15 pm ET
Nov 09, 2023 03:15 pm ET
Oct 26, 2023 05:30 pm ET
Oct 26, 2023 05:30 pm ET
Oct 24, 2023 07:50 am ET
Aurora Cannabis Announces Settlement of Patent Litigation
NASDAQ | TSX: ACB
Oct 24, 2023 07:50 am ET
Aurora Cannabis Announces Settlement of Patent Litigation
NASDAQ | TSX: ACB
Oct 03, 2023 08:59 am ET
Oct 03, 2023 08:59 am ET
Sep 28, 2023 07:10 am ET
Aurora Cannabis Inc. Announces C$34 Million Bought Deal Financing Intends to Repay Remaining Convertible Debt Balance
/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/
Sep 19, 2023 08:05 am ET
Aurora Launches Bold New Brand Tasty's into Canadian Adult Market
NASDAQ | TSX: ACB
Sep 19, 2023 08:05 am ET
Aurora Launches Bold New Brand Tasty's into Canadian Adult Market
NASDAQ | TSX: ACB
Sep 19, 2023 07:00 am ET
Sep 19, 2023 07:00 am ET
Sep 08, 2023 05:30 pm ET
Sep 07, 2023 09:42 am ET
Sep 06, 2023 07:50 am ET
Aug 14, 2023 05:30 pm ET
Aurora Cannabis Announces Results of 2023 Annual General Meeting
NASDAQ | TSX: ACB
Aug 10, 2023 04:15 pm ET
Aurora Cannabis Announces Fiscal 2024 First Quarter Results, and Delivers Record Positive Adjusted EBITDA
Achieves Quarterly Net Revenue1 of $75.1 Million; Strong YoY Growth Across All Business Units; Global Medical Cannabis +14%, Consumer Cannabis +5%, Plant Propagation +12%Delivers Third Sequential Quarter of Positive Adjusted EBITDA1, Supported by Bevo's Record Quarterly Revenue Cash Used in Operating Activities Reduced by $15.5 Million YoY, Re-Affirms Target of Positive Free Cash Flow in Calendar Year 2024NASDAQ | TSX: ACB
Aug 01, 2023 07:06 am ET
Aug 01, 2023 07:06 am ET
Jul 27, 2023 05:30 pm ET
Jul 27, 2023 05:30 pm ET
Jul 24, 2023 07:00 am ET
Jul 24, 2023 07:00 am ET
Jul 19, 2023 05:30 pm ET
Aurora Cannabis Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General Meeting of Shareholders
Your vote is important no matter how many shares you own. Vote today.Shareholders who have questions or need assistance with voting their shares should contact Aurora Cannabis Inc.'s strategic advisor and proxy solicitation agent, Laurel Hill Advisory Group, by telephone at 1-877-452-7184 or by email at [email protected], AB, July 19, 2023 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, is pleased to announce its notice of annual general meeting of shareholders and management information c
Jul 19, 2023 05:30 pm ET
Aurora Cannabis Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General Meeting of Shareholders
Your vote is important no matter how many shares you own. Vote today.Shareholders who have questions or need assistance with voting their shares should contact Aurora Cannabis Inc.'s strategic advisor and proxy solicitation agent, Laurel Hill Advisory Group, by telephone at 1-877-452-7184 or by email at [email protected], AB, July 19, 2023 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, is pleased to announce its notice of annual general meeting of shareholders and management inform
Jun 14, 2023 07:00 am ET
Jun 07, 2023 07:00 am ET
Jun 07, 2023 07:00 am ET
Jun 06, 2023 07:05 am ET
Aurora Celebrates Summer with New Innovation Launching Across Canada
NASDAQ | TSX: ACB
Jun 06, 2023 07:05 am ET
Aurora Celebrates Summer with New Innovation Launching Across Canada
NASDAQ | TSX: ACB
May 30, 2023 07:00 am ET
May 30, 2023 07:00 am ET
Apr 28, 2023 05:15 pm ET
Apr 28, 2023 05:15 pm ET
Apr 26, 2023 09:57 am ET
Apr 26, 2023 09:57 am ET
Apr 25, 2023 07:10 am ET
Aurora Introduces Fresh Innovation for Spring
New additions to lineup include two original cultivars from Aurora's breeding program, strain-specific gummies, aromatic vapes and terpy diamonds & sauce
Apr 25, 2023 07:10 am ET
Aurora Introduces Fresh Innovation for Spring
New additions to lineup include two original cultivars from Aurora's breeding program, strain-specific gummies, aromatic vapes and terpy diamonds & sauce
Apr 24, 2023 05:15 pm ET
Apr 24, 2023 05:15 pm ET
Apr 12, 2023 07:10 am ET
Aurora and MedReleaf Australia Launch IndiMed Tempo 26, Further Strengthening Product Offerings for Medical Cannabis Patients
Available through MedReleaf's Concession Scheme, doctors and patients will have more freedom in choosing their cannabis medication
Apr 12, 2023 07:10 am ET
Aurora and MedReleaf Australia Launch IndiMed Tempo 26, Further Strengthening Product Offerings for Medical Cannabis Patients
Available through MedReleaf's Concession Scheme, doctors and patients will have more freedom in choosing their cannabis medication
Mar 30, 2023 05:30 pm ET
Mar 30, 2023 05:30 pm ET
Mar 24, 2023 06:00 pm ET
Aurora Provides Update on Nasdaq Listing
NASDAQ | TSX: ACB
Mar 24, 2023 06:00 pm ET
Aurora Provides Update on Nasdaq Listing
NASDAQ | TSX: ACB
Mar 17, 2023 05:15 pm ET
Aurora Cannabis Announces Filing of Preliminary Base Shelf Prospectus
NASDAQ | TSX: ACB
Mar 17, 2023 05:15 pm ET
Aurora Cannabis Announces Filing of Preliminary Base Shelf Prospectus
NASDAQ | TSX: ACB
Mar 02, 2023 06:10 am ET
Aurora Launches New Medical Flower Product, Valour - Designed for Veterans, by Veterans
Proceeds from Valour sales to support veteran organizations across Canada
Feb 22, 2023 06:10 am ET
Feb 09, 2023 03:10 pm ET
Aurora Cannabis Announces Fiscal 2023 Second Quarter Results
NASDAQ | TSX: ACB
Feb 09, 2023 03:10 pm ET
Aurora Cannabis Announces Fiscal 2023 Second Quarter Results
NASDAQ | TSX: ACB
Jan 26, 2023 06:00 am ET
Aurora Cannabis to Host Second Quarter Fiscal Year 2023 Investor Conference Call
EDMONTON, AB, Jan. 26, 2023 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has scheduled a conference call to discuss the results for its second quarter fiscal year 2023 on Thursday, February 9, 2023 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time. The Company will report its financial results for the second quarter fiscal year 2023 after the close of markets that same day.
Jan 26, 2023 06:00 am ET
Aurora Cannabis to Host Second Quarter Fiscal Year 2023 Investor Conference Call
EDMONTON, AB, Jan. 26, 2023 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has scheduled a conference call to discuss the results for its second quarter fiscal year 2023 on Thursday, February 9, 2023 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time. The Company will report its financial results for the second quarter fiscal year 2023 after the close of markets that same day.
Jan 04, 2023 06:00 am ET
Jan 04, 2023 06:00 am ET
Dec 09, 2022 10:35 am ET
Dec 09, 2022 10:35 am ET
Dec 05, 2022 06:00 am ET
Dec 05, 2022 06:00 am ET
Nov 22, 2022 05:00 am ET
High Tide Becomes Top Revenue-Generating Cannabis Company in Canada
Data recently released by New Cannabis Ventures shows that the Company is now the largest revenue-generating company reporting in Canadian dollars.
Nov 22, 2022 05:00 am ET
High Tide Becomes Top Revenue-Generating Cannabis Company in Canada
Data recently released by New Cannabis Ventures shows that the Company is now the largest revenue-generating company reporting in Canadian dollars.
Nov 14, 2022 05:09 pm ET
Nov 14, 2022 05:09 pm ET
Nov 10, 2022 03:10 pm ET
Aurora Cannabis Announces Fiscal 2023 First Quarter Results
NASDAQ | TSX: ACB
Nov 10, 2022 03:10 pm ET
Aurora Cannabis Announces Fiscal 2023 First Quarter Results
NASDAQ | TSX: ACB
Oct 27, 2022 07:00 am ET
Oct 27, 2022 07:00 am ET
Oct 18, 2022 05:02 pm ET
Oct 18, 2022 05:02 pm ET
Oct 17, 2022 07:52 am ET
Aurora Announces Unprecedented Fall Product Release Across Adult-Use and Medical Markets
Aurora medical patients now have expanded access to company's full portfolio of adult-use cannabis brands
Oct 17, 2022 07:52 am ET
Aurora Announces Unprecedented Fall Product Release Across Adult-Use and Medical Markets
Aurora medical patients now have expanded access to company's full portfolio of adult-use cannabis brands
Oct 07, 2022 07:00 am ET
Oct 07, 2022 07:00 am ET
Sep 20, 2022 04:15 pm ET
Aurora Cannabis Announces Fiscal 2022 Fourth Quarter and Full Year Results
Remains #1 Canadian LP in High Margin Global Medical Cannabis Revenues; International Medical Cannabis Net Revenue Increased 35.4% from Q4 2021 and 70.3% from Fiscal 2021Reiterates Adjusted EBITDA Profitability Run Rate by December 31, 2022Reaffirms $150 to $170 Million in Annualized Cost Savings by December 31, 2022Strengthens Balance Sheet Through Accretive Debt Reduction Totaling $155.3 Million in Q4 2022Completed Profitable Acquisition of Thrive Cannabis and Majority Investment in Bevo FarmsEDMONTON, AB, Sept. 20, 2022 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB
Sep 20, 2022 04:15 pm ET
Aurora Cannabis Announces Fiscal 2022 Fourth Quarter and Full Year Results
Remains #1 Canadian LP in High Margin Global Medical Cannabis Revenues; International Medical Cannabis Net Revenue Increased 35.4% from Q4 2021 and 70.3% from Fiscal 2021Reiterates Adjusted EBITDA Profitability Run Rate by December 31, 2022Reaffirms $150 to $170 Million in Annualized Cost Savings by December 31, 2022Strengthens Balance Sheet Through Accretive Debt Reduction Totaling $155.3 Million in Q4 2022Completed Profitable Acquisition of Thrive Cannabis and Majority Investment in Bevo FarmsEDMONTON, AB, Sept. 20, 2022 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASD
Sep 02, 2022 05:15 pm ET
S&P Dow Jones Indices Announces Changes to the S&P/TSX Composite Index and S&P/TSX 60 Index
TORONTO, Sept. 2, 2022 /CNW/ - As a result of the quarterly review, S&P Dow Jones Indices will make the following changes in the S&P/TSX Composite Index and S&P/TSX 60 Index prior to the open of trading on Monday, September 19, 2022:
Aug 29, 2022 05:00 pm ET
Aug 29, 2022 05:00 pm ET
Aug 25, 2022 07:05 am ET
Aurora Cannabis Acquires Controlling Interest in Bevo Farms
NASDAQ | TSX: ACB
Aug 25, 2022 07:05 am ET
Aurora Cannabis Acquires Controlling Interest in Bevo Farms
NASDAQ | TSX: ACB
Jun 03, 2022 07:00 am ET
Aurora Cannabis Repurchases US$20 Million of Convertible Notes
Aurora Further Strengthens Balance Sheet with Accretive Debt Reduction
Jun 03, 2022 07:00 am ET
Aurora Cannabis Repurchases US$20 Million of Convertible Notes
Aurora Further Strengthens Balance Sheet with Accretive Debt Reduction
Jun 01, 2022 08:53 am ET
IIROC Trade Resumption - ACB.WS.U
TORONTO, June 1, 2022 /CNW/ - Trading resumes in:
Jun 01, 2022 08:30 am ET
Aurora Cannabis Inc. Closes Previously Announced Bought Deal Financing
NASDAQ | TSX: ACB
Jun 01, 2022 08:30 am ET
Aurora Cannabis Inc. Closes Previously Announced Bought Deal Financing
NASDAQ | TSX: ACB
Jun 01, 2022 08:07 am ET
IIROC Trading Halt - ACB.WS.U
TORONTO, June 1, 2022 /CNW/ - The following issues have been halted by IIROC:
May 27, 2022 09:13 am ET
May 27, 2022 09:13 am ET
May 26, 2022 04:33 pm ET
Aurora Cannabis Inc. Announces US$125 Million Bought Deal Financing
EDMONTON, AB, May 26, 2022 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today has announced today that it has entered into an agreement with a syndicate of underwriters led by Canaccord Genuity and BMO Capital Markets, under which the underwriters have agreed to buy on bought deal basis 51.1 million units of the Company (the "Units"), at a price of US$2.45 per Unit for gross proceeds of approximately US$125.2 million (the "Offering"). Each Unit will be comprised of one common share of t
May 26, 2022 04:33 pm ET
Aurora Cannabis Inc. Announces US$125 Million Bought Deal Financing
EDMONTON, AB, May 26, 2022 /PRNewswire/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today has announced today that it has entered into an agreement with a syndicate of underwriters led by Canaccord Genuity and BMO Capital Markets, under which the underwriters have agreed to buy on bought deal basis 51.1 million units of the Company (the "Units"), at a price of US$2.45 per Unit for gross proceeds of approximately US$125.2 million (the "Offering"). Each Unit will be comprised of one common sha
May 18, 2022 07:05 am ET
Aurora Strengthens Leadership Position in Germany with EU-GMP Certification at Preeminent Local Cannabis Production Facility
State-of-the-art facility readying first delivery of medical grade cannabis for German patients
May 18, 2022 07:05 am ET
Aurora Strengthens Leadership Position in Germany with EU-GMP Certification at Preeminent Local Cannabis Production Facility
State-of-the-art facility readying first delivery of medical grade cannabis for German patients
May 12, 2022 04:15 pm ET
Aurora Cannabis Announces Fiscal 2022 Third Quarter Results
Increasing Original Target for Expense Savings; Management Now Expects $150 to $170 Million in Annualized Cost Savings by H1/2023 versus Stated Target of $60 to $80 MillionReiterating Adjusted EBITDA Profitability Run Rate by the End of Fiscal H1 2023Remains #1 Canadian LP in High Margin Global Medical Cannabis Revenues; International Medical Revenue Increased 55% from Q3 2021Strong balance sheet; Early Repurchase of $141.4 Million in Convertible DebtEDMONTON, AB, May 12, 2022 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defin
May 12, 2022 04:15 pm ET
Aurora Cannabis Announces Fiscal 2022 Third Quarter Results
Increasing Original Target for Expense Savings; Management Now Expects $150 to $170 Million in Annualized Cost Savings by H1/2023 versus Stated Target of $60 to $80 MillionReiterating Adjusted EBITDA Profitability Run Rate by the End of Fiscal H1 2023Remains #1 Canadian LP in High Margin Global Medical Cannabis Revenues; International Medical Revenue Increased 55% from Q3 2021Strong balance sheet; Early Repurchase of $141.4 Million in Convertible DebtEDMONTON, AB, May 12, 2022 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the
May 05, 2022 04:00 pm ET
May 05, 2022 04:00 pm ET
May 03, 2022 05:03 pm ET
Aurora Cannabis to Host Third Quarter Fiscal Year 2022 Investor Conference Call
EDMONTON, AB, May 3, 2022 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has scheduled a conference call to discuss the results for its third quarter fiscal year 2022 on Thursday, May 12, 2022 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time. The Company will report its financial results for the third quarter fiscal year 2022 after the close of markets that same day.
May 03, 2022 05:03 pm ET
Aurora Cannabis to Host Third Quarter Fiscal Year 2022 Investor Conference Call
EDMONTON, AB, May 3, 2022 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has scheduled a conference call to discuss the results for its third quarter fiscal year 2022 on Thursday, May 12, 2022 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time. The Company will report its financial results for the third quarter fiscal year 2022 after the close of markets that same day.
Mar 28, 2022 07:50 am ET
CANNABIS AMNESTY PARTNERS WITH TOQi, AURORA CANNABIS TO CREATE ECONOMIC OPPORTUNITY WITH FIRST TOQi FELLOWSHIP
Fellowship Aims to Bring Justice + Equality to Communities Harmed by Cannabis Criminalization; Applications Now Open for Two Summer Interns
Mar 22, 2022 06:06 pm ET
Aurora Cannabis Advances Premiumization Strategy by Acquiring Thrive Cannabis, and its Award-Winning Greybeard Brand, in a Margin Accretive Transaction
Thrive's highly experienced and trusted cannabis team in craft cultivation, product innovation, and operational execution will lead Aurora's Canadian recreational business Expands Aurora's brand offering with Greybeard, an award-winning, super-premium, high margin brand regarded for its budtender appreciation Transaction is expected to close in Aurora's Q4 fiscal 2022, contribute immediate positive EBITDA and support Aurora's goal to reach EBITDA profitability in the first half of fiscal 2023NASDAQ | TSX: ACB
Mar 22, 2022 06:06 pm ET
Aurora Cannabis Advances Premiumization Strategy by Acquiring Thrive Cannabis, and its Award-Winning Greybeard Brand, in a Margin Accretive Transaction
Thrive's highly experienced and trusted cannabis team in craft cultivation, product innovation, and operational execution will lead Aurora's Canadian recreational business Expands Aurora's brand offering with Greybeard, an award-winning, super-premium, high margin brand regarded for its budtender appreciation Transaction is expected to close in Aurora's Q4 fiscal 2022, contribute immediate positive EBITDA and support Aurora's goal to reach EBITDA profitability in the first half of fiscal 2023NASDAQ | TSX: ACB
Feb 10, 2022 03:15 pm ET
Aurora Cannabis Announces Fiscal 2022 Second Quarter Results
Global Cannabis Net Revenue of $60.6 MillionAdjusted EBITDA Improved by 22% to a loss of $9.0 Million versus Q1 2022 Company Reaffirms Goal of Adjusted EBITDA Profitability by H1/2023Transformation Plan Ahead of Schedule; Company Now Expects to Realize Upper End of $60 to $80 Million Range in Total Cost Savings by H1/2023; ~$60 Million Annualized Savings Implemented to DateCompany Remains #1 Canadian LP in Global Medical Cannabis; International Cannabis Revenue Increased 24% from Q1 2022NASDAQ | TSX: ACB
Feb 03, 2022 06:13 am ET
Aurora Cannabis's Reliva Expands Portfolio with New CBD Brand, KG7
NASDAQ | TSX: ACB
Feb 01, 2022 04:03 pm ET
Jan 04, 2022 06:00 am ET
Jan 04, 2022 06:00 am ET
Jan 04, 2022 05:50 am ET
Aurora Cannabis Announces New Director and Updates to The Board
Newly created directorship to be filled by Chitwant Kohli, Senior Financial Executive
Jan 04, 2022 05:50 am ET
Aurora Cannabis Announces New Director and Updates to The Board
Newly created directorship to be filled by Chitwant Kohli, Senior Financial Executive
Dec 14, 2021 03:05 pm ET
Aurora and 22nd Century Group License Foundational Biosynthesis IP to Cronos Group
Licensing deal set to assist in the advancement of research and development for cannabinoid biosynthesis
Dec 14, 2021 03:05 pm ET
Aurora and 22nd Century Group License Foundational Biosynthesis IP to Cronos Group
Licensing deal set to assist in the advancement of research and development for cannabinoid biosynthesis
Dec 13, 2021 06:20 am ET
Nov 22, 2021 06:14 am ET
Aurora Sponsors Cannabis Amnesty to Support Next Phase of Cannabis Advocacy
EDMONTON, AB, Nov. 22, 2021 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced a renewed sponsorship of Cannabis Amnesty in support of their advocacy work, calling for blanket pardons to all individuals for the offence of simple possession of cannabis. The sponsorship will support Cannabis Amnesty's campaign to right these historical wrongs – especially the impact on racialized communities.
Nov 16, 2021 06:00 am ET
Aurora Builds on a Decade of Global Leadership in Plant Genetics with the Launch of Occo
Genetics and licensing business will be led by new hire, Casey Whelan, VP, Genetics Business Development
Nov 16, 2021 06:00 am ET
Aurora Builds on a Decade of Global Leadership in Plant Genetics with the Launch of Occo
Genetics and licensing business will be led by new hire, Casey Whelan, VP, Genetics Business Development
Nov 12, 2021 04:20 pm ET
Aurora Cannabis Announces Results of 2021 Annual General Meeting
NASDAQ | TSX: ACB
Nov 12, 2021 04:20 pm ET
Aurora Cannabis Announces Results of 2021 Annual General Meeting
NASDAQ | TSX: ACB
Nov 09, 2021 03:15 pm ET
Aurora Cannabis Announces Fiscal 2022 First Quarter Results
Transformation Plan On Track; Actions Taken-to-Date Have Driven Over $33 Million in Annualized Run-Rate Cost Savings Total Cannabis Net Revenue, Net of Provisions, Grew ~10% to $60.1 million Compared to $54.8 Million in Q4 2021 Adjusted EBITDA Excluding Restructuring Costs Improved by $4.0 million to a loss of $11.5 million versus Q4 2021; Clear Pathway to Adjusted EBITDA Profitability by H1/FY23 Improved Adjusted Gross Margin before FVA of 54% versus 53% in Q4 2021 EDMONTON, AB, Nov. 9, 2021 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canad
Nov 09, 2021 03:15 pm ET
Aurora Cannabis Announces Fiscal 2022 First Quarter Results
Transformation Plan On Track; Actions Taken-to-Date Have Driven Over $33 Million in Annualized Run-Rate Cost Savings Total Cannabis Net Revenue, Net of Provisions, Grew ~10% to $60.1 million Compared to $54.8 Million in Q4 2021 Adjusted EBITDA Excluding Restructuring Costs Improved by $4.0 million to a loss of $11.5 million versus Q4 2021; Clear Pathway to Adjusted EBITDA Profitability by H1/FY23 Improved Adjusted Gross Margin before FVA of 54% versus 53% in Q4 2021 EDMONTON, AB, Nov. 9, 2021 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian com
Nov 08, 2021 06:00 am ET
Aurora Cannabis Acquires a Significant Equity Stake in Growery B.V., One of 10 Successful Applicants for a Cannabis Production Licence in the Netherlands
First Federally Regulated Recreational Market in Europe and Largest Outside of Canada
Nov 08, 2021 06:00 am ET
Aurora Cannabis Acquires a Significant Equity Stake in Growery B.V., One of 10 Successful Applicants for a Cannabis Production Licence in the Netherlands
First Federally Regulated Recreational Market in Europe and Largest Outside of Canada
Oct 28, 2021 07:00 am ET
Aurora Announces Manufacturing Agreement with The Valens Company
New Seasonal Offerings Slated for November Release
Oct 28, 2021 07:00 am ET
Aurora Announces Manufacturing Agreement with The Valens Company
New Seasonal Offerings Slated for November Release
Oct 26, 2021 05:00 pm ET
Aurora Cannabis to Host First Quarter Fiscal Year 2022 Investor Conference Call
EDMONTON, AB, Oct. 26, 2021 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has scheduled a conference call to discuss the results for its first quarter fiscal year 2022 on Tuesday, November 9, 2021 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time. The Company will report its financial results for the first quarter fiscal year 2022 after the close of markets that same day.
Oct 26, 2021 05:00 pm ET
Aurora Cannabis to Host First Quarter Fiscal Year 2022 Investor Conference Call
EDMONTON, AB, Oct. 26, 2021 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has scheduled a conference call to discuss the results for its first quarter fiscal year 2022 on Tuesday, November 9, 2021 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time. The Company will report its financial results for the first quarter fiscal year 2022 after the close of markets that same day.
Oct 12, 2021 08:00 am ET
Sep 29, 2021 04:10 pm ET
Aurora Cannabis Launches its First Medical CBD Product in Uruguay
NASDAQ | TSX: ACB
Sep 29, 2021 04:10 pm ET
Aurora Cannabis Launches its First Medical CBD Product in Uruguay
NASDAQ | TSX: ACB
Sep 27, 2021 04:15 pm ET
Aurora Cannabis Announces Fiscal 2021 Fourth Quarter Results
NASDAQ | TSX: ACB
Sep 27, 2021 04:15 pm ET
Aurora Cannabis Announces Fiscal 2021 Fourth Quarter Results
NASDAQ | TSX: ACB
Sep 20, 2021 04:31 pm ET
Sep 20, 2021 04:31 pm ET
Sep 07, 2021 05:00 pm ET
Sep 07, 2021 05:00 pm ET
Aug 25, 2021 06:50 am ET
Aug 25, 2021 06:50 am ET
Jul 26, 2021 06:58 am ET
Aurora Cannabis Announces Appointment of New Independent Director
Distinguished senior healthcare executive, Theresa Firestone, to fill newly added position
Jul 26, 2021 06:58 am ET
Aurora Cannabis Announces Appointment of New Independent Director
Distinguished senior healthcare executive, Theresa Firestone, to fill newly added position
Jul 15, 2021 06:58 am ET
Aurora Cannabis Delivers $8 Million Shipment of Cannabis to Israel
Shipment is part of the Company's strategy to advance its leadership in the global cannabinoid space
Jul 15, 2021 06:58 am ET
Aurora Cannabis Delivers $8 Million Shipment of Cannabis to Israel
Shipment is part of the Company's strategy to advance its leadership in the global cannabinoid space
Jun 09, 2021 10:13 am ET
Aurora Cannabis expands San Rafael '71 portfolio with the launch of three new proprietary cultivars for Canadian consumer market
First ever adult-use cultivars Aurora has commercialized from Aurora Coast R&D facility
Jun 01, 2021 05:00 pm ET
Aurora Cannabis Completes Balance Sheet Restructuring
Full Repayment of Credit Facility Results in Principal and Interest Savings of ~$25 Million In the Next Year
May 28, 2021 03:50 pm ET
May 27, 2021 07:00 am ET
New Science & Innovation Business Unit to Advance Aurora's Leadership in Biosynthesis and Plant Genetics
The Company's patented technology expected to be key to commercial success in cannabinoid biosynthesis
May 24, 2021 05:00 pm ET
May 20, 2021 03:40 pm ET
May 20, 2021 07:30 am ET
May 14, 2021 04:01 pm ET
Aurora to Participate in BMO Capital Markets Farm to Market Virtual Conference
EDMONTON, AB, May 14, 2021 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced that the Company will be participating at the BMO Capital Markets 16th Annual Farm to Market Virtual Conference. Chief Executive Officer, Miguel Martin, and Chief Financial Officer, Glen Ibbott, will be conducting virtual one-on-one meetings with investors throughout the day on Wednesday, May 19 and Thursday, May 20, 2021.
May 13, 2021 04:15 pm ET
Aurora Cannabis Announces Fiscal 2021 Third Quarter Results
Domestic Medical Net Revenue Steady at $26.9 Million Strong International Medical Net Revenue of $9.4 Million Total Cannabis Net Revenue, Excluding Provisions, of $58.4 Million Business Transformation Plan Continues, Management Expects to Deliver Incremental Cost-Saving Measures of $60 Million to $80 Million Annually Balance Sheet Remains Strong with ~$525 Million of Cash on Hand at May 12, 2021 Lead Independent Director Ronald Funk Appointed as Chairman, Michael Singer to Remain Board MemberNYSE | TSX: ACB
Apr 30, 2021 07:00 am ET
Mar 10, 2021 12:32 pm ET
Feb 11, 2021 03:10 pm ET
Aurora Cannabis Announces Fiscal 2021 Second Quarter Results
Total Cannabis Net Revenue of $70.3 Million, Excluding Provisions of $2.7 Million, Up 11% over Q2 2020Medical Cannabis Net Revenue of $38.9 Million, Up 42% Versus Q2 2020, Driven by a 562% Increase in High Margin International Medical SalesAdjusted EBITDA Loss, excluding Provisions and Termination Costs, of $12.1 Million Represents an Improvement of $53.1 Million Over Q2 2020; Current Loss Triggered by Several Decisions Expected to Boost Long-Term ProfitabilityImproved Cash Use by More Than 74% Versus Q2 2020; Cash on Hand at February 10, 2021 of $565 MillionNYSE | TSX: ACB
Feb 11, 2021 03:10 pm ET
Aurora Cannabis Announces Fiscal 2021 Second Quarter Results
Total Cannabis Net Revenue of $70.3 Million, Excluding Provisions of $2.7 Million, Up 11% over Q2 2020Medical Cannabis Net Revenue of $38.9 Million, Up 42% Versus Q2 2020, Driven by a 562% Increase in High Margin International Medical SalesAdjusted EBITDA Loss, excluding Provisions and Termination Costs, of $12.1 Million Represents an Improvement of $53.1 Million Over Q2 2020; Current Loss Triggered by Several Decisions Expected to Boost Long-Term ProfitabilityImproved Cash Use by More Than 74% Versus Q2 2020; Cash on Hand at February 10, 2021 of $565 MillionNYSE | TSX: ACB
Jan 28, 2021 06:00 am ET
Jan 28, 2021 06:00 am ET
Jan 27, 2021 04:00 pm ET
Aurora Cannabis and MedReleaf Australia Announce Strategic Agreement
Broadest Medical Cannabis Product Range in Australian Market
Jan 27, 2021 04:00 pm ET
Aurora Cannabis and MedReleaf Australia Announce Strategic Agreement
Broadest Medical Cannabis Product Range in Australian Market
Jan 26, 2021 09:06 am ET
Jan 26, 2021 09:06 am ET
Jan 26, 2021 09:02 am ET
Aurora Cannabis Closes Previously Announced Bought Deal Financing
Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of...
Jan 26, 2021 08:19 am ET
IIROC Trade Resumption - ACB.WT.V
TORONTO, Jan. 26, 2021 /CNW/ - Trading resumes in:
Jan 26, 2021 07:13 am ET
IIROC Trading Halt - ACB.WT.V
TORONTO, Jan. 26, 2021 /CNW/ - The following issues have been halted by IIROC:
Jan 21, 2021 04:41 pm ET
Jan 21, 2021 04:41 pm ET
Jan 21, 2021 04:16 pm ET
Aurora Cannabis Inc. Announces US$125 Million Bought Deal Financing
Aurora Cannabis Inc. (“Aurora” or the “Company”) has announced today that it has entered into an agreement with a syndicate of underwriters led by BMO Capital Markets and ATB Capital Markets, under which the underwriters have agreed to buy on...
Jan 14, 2021 01:00 pm ET
Aurora Announces Agreement with Great North Distributors Inc. For Canadian Retail Sales Execution
Great North will be exclusive representative for Aurora's leading portfolio of Canadian brands
Jan 14, 2021 01:00 pm ET
Aurora Announces Agreement with Great North Distributors Inc. For Canadian Retail Sales Execution
Great North will be exclusive representative for Aurora's leading portfolio of Canadian brands
Dec 16, 2020 06:00 am ET
Aurora Cannabis Announces Operational & Balance Sheet Improvements
Revised Credit Facility Terms Supports Execution of Business Transformation Plan that Focuses on Long-Term, Sustainable Revenue Growth & Improving Operating Cashflow
Dec 16, 2020 06:00 am ET
Aurora Cannabis Announces Operational & Balance Sheet Improvements
Revised Credit Facility Terms Supports Execution of Business Transformation Plan that Focuses on Long-Term, Sustainable Revenue Growth & Improving Operating Cashflow
Dec 04, 2020 09:38 am ET
Cannabis Profits In Focus: CEO’s of HEXO, Icanic Brands, Tilray, and Aurora Cannabis Discuss Next Wave of Global Growth Opportunities and Brands Innovation
Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN), Aurora Cannabis (NYSE: ACB) (TSX:...
Nov 25, 2020 06:00 am ET
Aurora Cannabis Announces Israeli Medical Supply Agreement with Cantek
Aurora strategically positioned within two of the largest legal cannabis markets outside of Canada Agreement with Israeli leader Cantek provides access to Israel's drugstore channel Finished product is co-branded under Aurora and Cantek brandsNYSE | TSX: ACB
Nov 25, 2020 06:00 am ET
Aurora Cannabis Announces Israeli Medical Supply Agreement with Cantek
Aurora strategically positioned within two of the largest legal cannabis markets outside of Canada Agreement with Israeli leader Cantek provides access to Israel's drugstore channel Finished product is co-branded under Aurora and Cantek brandsNYSE | TSX: ACB
Nov 24, 2020 09:56 am ET
CEO’s of Tilray, Icanic Brands, Canopy Growth, and Aurora Cannabis Discuss Next Phase of Global Growth Opportunities and Brands Innovation
Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN), Aurora Cannabis (NYSE: ACB)(TSX:...
Nov 16, 2020 09:28 am ET
Aurora Cannabis Closes Previously Announced Upsized Underwritten Public Offering
Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced overnight marketed public offering (the “Offering”) of...
Nov 16, 2020 09:00 am ET
Nov 16, 2020 09:00 am ET
Nov 16, 2020 08:40 am ET
IIROC Trade Resumption - ACB.WT.U
TORONTO, Nov. 16, 2020 /CNW/ - Trading resumes in:
Nov 16, 2020 07:02 am ET
IIROC Trading Halt - ACB.WT.U
TORONTO, Nov. 16, 2020 /CNW/ - The following issues have been halted by IIROC:
Nov 16, 2020 06:00 am ET
Nov 16, 2020 06:00 am ET
Nov 11, 2020 09:13 am ET
Aurora Cannabis Prices US$150 Million Underwritten Public Offering
Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the pricing of its previously announced overnight marketed public offering (the “Offering”) of...
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Interactive technical study charts by TradingView. Copyright © 2024 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.
